Tigecycline-Associated Mortality Imbalance in Patients With Serious Infections
Alternatives to tigecycline “should be considered” when treating patients with serious infections because the intravenous antibiotic has been associated with an increased mortality rate in this population, according to a safety alert issued by the Food and Drug Administration on Sept. 1.